The Board of Directors of IDEX Biometrics ASA (the Company) resolved on 19 August 2026 to issue 550,000 incentive subscription rights (SRs) to 2 employees in IDEX Biometrics. The grant was made under the Company's 2026 incentive subscription rights plan as resolved at the Annual General Meeting on 29 May 2026. The exercise price of the subscription rights is NOK 8.00 per share for 90% of the granted subscription rights while the remaining 10% of the subscription rights will have an exercise price of NOK 1.00 pr share. This split applies for each individual recipient of subscription rights. The SRs will become vested over three years from the date of grant in equal quarterly increments. The SRs expire on 29 May 2031. Following the Company's recent restructuring it is the intention of the Board to retain and incentivize continuing employees of the company.
Following these grants there are 5.245.681 incentive subscription rights outstanding in IDEX Biometrics.
Primary insiders
IDEX discloses transactions by the following primary insiders, who were granted incentive subscription rights (SRs) to IDEX shares:
- CEO Kjell-Arne Besseberg was granted 400,000 SRs at NOK 8.00 and NOK 1.00 per share (split 90%/10%)
- CFO Ingvill Tømt was granted 150,000 SRs at NOK 8.00 per share and NOK 1.00 per share (split 90%/10%)
Contacts
Anders Storbråten, Executive Chairman, Tel: +47 416 38 582
E-mail: ir@idexbiometrics.com
About Us
IDEX Biometrics ASA (OSE: IDEX) develops and makes fingerprint biometric cards for access control, digital identity and payment. By authenticating identity through fingerprint biometrics rather than passwords, PINs or traditional credentials, IDEX enables secure and convenient access to physical and digital services. Fingerprint matching happens directly on the card, offline and without transmitting biometric data. Certified by Visa, Mastercard, FIDO2 and EAL6+, and backed by more than 250 patents and over USD 350 million invested in R&D, IDEX serves banks, enterprises and public sector organizations directly and through channel partners worldwide.
For more information, visit www.idexbiometrics.com
This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-08-25 23:45 CEST.